معرفی
Professor Stephen Holgate is a leading clinical scientist at the University of Southampton's Faculty of Medicine, specializing in immunopharmacology and respiratory diseases. His research spans asthma pathogenesis, COPD exacerbation mechanisms, SARS-CoV-2 interactions, air pollution effects, and epithelial-mesenchymal biology.
- Medical Research Council Clinical Professor of Immunopharmacology (1987–present)
- Honorary Consultant Physician, University Hospital Southampton
Research Focus:
- Identified allergen-driven IgE inflammation as a core asthma mechanism
- Discovered epithelial barrier dysfunction as a unifying platform for asthma triggers
- Developed inhaled interferon-beta therapy for viral exacerbations in asthma/COPD
- Linked air pollution (NO2, PM2.5) to new asthma incidence and viral exacerbation
- Cloned asthma susceptibility gene ADAM33, now a therapeutic target
Scientific Leadership:
- Chaired WHO/NHLBI Global Initiative for Asthma (GINA) Expert Panel
- Co-founded Synairgen (respiratory antiviral therapeutics)
- UKRI Clean Air Champion (2019–present)
- Contributed to WHO Air Quality Guidelines and UK Daily Air Quality Index
Honors and Recognition:
- Knight Commander of the Order of the British Empire (2020)
- Khwarizmi International Award (2019)
- World Allergy Organization Lifetime Achievement Award (2019)
- Multiple presidential and international medals (2014–2020)
۰مقاله منتشرشده
